Advancing Education. Elevating Care. Improving Outcomes.
At BD Interventional-Peripheral Intervention, we are committed to advancing clinical excellence through education. Our comprehensive training programs are designed to strengthen procedural skills, accelerate learning, and support best practices in patient care.
Through innovative formats and evidence-based content, we help healthcare professionals stay at the forefront of clinical techniques and device utilization. By focusing on safe, effective product use and continuous professional development, we aim to improve outcomes and drive meaningful impact in healthcare.
BD Interventional-Peripheral Intervention provides a comprehensive suite of education and training programs designed to support healthcare professionals at every stage of their journey. From foundational product training and advanced procedural workshops to virtual learning modules, peer-to-peer programs and hands-on simulation, our offerings are built to enhance clinical proficiency and promote best practices. With flexible formats—online, in-person, and hybrid—we deliver impactful learning experiences that empower clinicians to improve patient outcomes.
At BD Intervention we believe better education drives better outcomes. Through the Advance Clinical Education & Training platform, we’ve created programs grounded in clinical relevance and designed to improve patient care.
Our mission is to empower healthcare professionals with the knowledge and skills needed to deliver safe, effective and innovative care.
Advance Clinical Education & Training is built on clinical insight, innovation, and collaboration—because when clinicians thrive, patients benefit.
Take your professional development to the next level with Advance Clinical Education and Training. Our platform offers a comprehensive range of resources designed to support your growth, whenever and wherever you need it.
Gain access to:
© 2025 BD. All rights reserved. BD and the BD logo are trademarks of Becton, Dickinson and Company or its affiliates.
BD-157918v2
Trial Name | Status/Details |
| Post-Market Surveillance Study of the BD® WavelinQ™ EndoAVF System (CONNECT-AV) | View Study |
| Post Approval Study Investigating Lutonix™ Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae (Lutonix AV-PAS) | View Study |
| Post Approval Study of the Covera™ Vascular Covered Stent (AVeNEW PAS) | View Study |
Trial Name | Status/Details |
| Prospective Multi-Center Study Evaluating Revello™ Vascular Covered Stent* (AGILITY) | View Study |
| Real World Registry Assessing the Clinical Use of the Bard® UltraScore™ Focused Force PTA Balloon | View Study |
| Real-World Registry of the Rotarex™ Rotational Excisional Atherectomy System (XTRACT) | View Study |
| Real-World Registry Assessing the Clinical Use of the Lutonix™ 035 Drug Coated Balloon Catheter (SAFE-DCB) | View Study |
Trial Name | Status/Details |
| Venclose digiRF™ System Post-Market Study | View Study |
| The BD Liverty™ TIPS Stent Graft Study – A Global, Prospective, Multi-Center, Single-Arm Clinical Study for the Treatment of Complications from Portal Hypertension (ARCH) | View Study |
© 2025 BD. All rights reserved. BD and the BD logo are trademarks of Becton, Dickinson and Company or its affiliates.
BD-157918v2